Tardive Dyskinesia Videos & Stories - AUSTEDO XR
AUSTEDO XR is a prescription medicine used to treat tardive dyskinesia in adults. AUSTEDO XR can cause depression, suicidal thoughts, or actions in patients with Huntington’s disease. Pay close …
Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine) …
The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis and insomnia. Adverse reactions …
TD NEWS & VIEWS
In this conversation, Jeremy Schreiber discusses the role of advanced practice providers (APPs) in screening, assessing, and treating tardive dyskinesia (TD). He details the impact of TD on patients …
Austedo for Tardive Dyskinesia - Philadelphia Integrative Psychiatry
May 17, 2024 · Please read our blog here for more on what tardive dyskinesia is, including a video reference. Studies have shown that approximately 67% of patients experience at least a 50% …
Teva puts a face on tardive dyskinesia in latest Austedo XR spots
Apr 1, 2024 · Teva Pharmaceuticals has been focused on treating tardive dyskinesia (TD), a side effect of taking medications for mental illness, for some time now. Around 500,000 patients experience TD, …
Real-world data shows AUSTEDO improves life for patients with tardive ...
Nov 11, 2025 · Teva Pharmaceuticals has announced new real-world data showing that AUSTEDO (deutetrabenazine) tablets and AUSTEDO XR (extended-release) tablets led to meaningful …
Study Explores Tardive Dyskinesia Outcomes With Deutetrabenazine …
Nov 12, 2024 · It demonstrates real-world treatment patterns and outcomes with once-daily Austedo XR (deutetrabenazine) extended-release tablets and twice-daily Austedo (deutetrabenazine) tablets, …
Clinical & Real-World Data | Tardive Dyskinesia (TD) | AUSTEDO ...
See the tardive dyskinesia (TD) clinical trial results for AUSTEDO. See Prescribing Information, including Boxed Warning.
AUSTEDO XR® Medication for Tardive Dyskinesia (TD)
Once-daily AUSTEDO XR® (deutetrabenazine) extended release tablets reduce uncontrollable Tardive Dyskinesia (TD) body movements. See safety info including Boxed Warning.
Teva Presents IMPACT-TD Data On Tardive Dyskinesia, Revealing …
Nov 2, 2024 · The IMPACT-TD Registry is the largest study of its kind evaluating the holistic effects of tardive dyskinesia (TD), showing real-world treatment patterns and outcomes with once-daily …